Cite
Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone.
MLA
Wada, Keiko, et al. “Sevoflurane-Based Enhancement of Phase-Amplitude Coupling and Localization of the Epileptogenic Zone.” Clinical Neurophysiology, vol. 134, Feb. 2022, pp. 1–8. EBSCOhost, https://doi.org/10.1016/j.clinph.2021.11.004.
APA
Wada, K., Sonoda, M., Firestone, E., Sakakura, K., Kuroda, N., Takayama, Y., Iijima, K., Iwasaki, M., Mihara, T., Goto, T., Asano, E., & Miyazaki, T. (2022). Sevoflurane-based enhancement of phase-amplitude coupling and localization of the epileptogenic zone. Clinical Neurophysiology, 134, 1–8. https://doi.org/10.1016/j.clinph.2021.11.004
Chicago
Wada, Keiko, Masaki Sonoda, Ethan Firestone, Kazuki Sakakura, Naoto Kuroda, Yutaro Takayama, Keiya Iijima, et al. 2022. “Sevoflurane-Based Enhancement of Phase-Amplitude Coupling and Localization of the Epileptogenic Zone.” Clinical Neurophysiology 134 (February): 1–8. doi:10.1016/j.clinph.2021.11.004.